Shaolin Capital Management’s SAB Biotherapeutics SABS Stock Holding History

Shaolin Capital Management’s Portfolio SABS Stock Details SABS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$140K	Sell
2022 Q3	$193K	Hold
2022 Q2	$399K	Hold
2022 Q1	$1.03M	Buy
2021 Q4	$1.87M	Sell
2021 Q3	$5.45M	Buy
2021 Q2	$5.32M	Buy
2021 Q1	$5.11M	Buy